AbbVie (ABBV) announced that it has completed its acquisition of Nimble Therapeutics. With the completion of the acquisition, Nimble is now a part of AbbVie.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie and Neomorph to codevelop molecular glue degraders for onchology
- Johnson & Johnson’s New Acquisition Could Result in Tremendous Rewards
- Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market
- Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
- Ozempic, Xtandi among next 15 drugs selected for U.S. price talks